SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-039375
Filing Date
2019-07-05
Accepted
2019-07-05 07:00:32
Documents
1
Period of Report
2019-07-03

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 14069
  Complete submission text file 0001104659-19-039375.txt   15261
Mailing Address
Business Address
JEFFS ROGER (Reporting) CIK: 0001231615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 19943165

Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations